Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-02-27

Clinical Trial Update: Impact if Desflurane Preconditioning on the Content of the Phospho-GSK-3b in the Rat's Neurons in the Model of I/R [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating desflurane preconditioning effects on phospho-GSK-3b content in rat neurons in an ischemia/reperfusion model has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DESFLURANE (DESFLURANE)

Snippet

Sponsor: Negovsky Reanimatology Research Institute | Conditions: Heart Arrest | Phase 4 | Status: WITHDRAWN